Consumer Goods Active Stocks: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM), The Coca-Cola Company (NYSE:KO)

Apple Inc. (NASDAQ:AAPL) is in talks with Internet and cable provider Comcast to create a special streaming television service available only to Apple TV users. Apple Inc. (NASDAQ:AAPL) stock performance was 1.19% in last session and finished the day at $539.19. Traded volume was 12,653,038 million shares in the last session and the average volume of the stock remained 11.53 million shares. The beta of … Continue reading Consumer Goods Active Stocks: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM), The Coca-Cola Company (NYSE:KO)

Basic Material Active Stocks: Alcoa Inc (NYSE:AA), Petroleo Brasileiro Petrobras (NYSE:PBR), North American Palladium (NYSEMKT:PAL), Barrick Gold (NYSE:ABX)

Shares of Alcoa (NYSE:AA) saw some unusual options trading activity on Monday. Investors purchased 35,778 call options on the company, AR Network reports. This is an increase of approximately 129% compared to the typical volume of 15,651 call options. Alcoa Inc (NYSE:AA) stock finished the day at $12.01. Traded volume was 28,890,184 million shares in the last session and the average volume of the stock … Continue reading Basic Material Active Stocks: Alcoa Inc (NYSE:AA), Petroleo Brasileiro Petrobras (NYSE:PBR), North American Palladium (NYSEMKT:PAL), Barrick Gold (NYSE:ABX)

The only therapy currently approved by the Food and Drug Administration to treat myelofibrosis, a disorder where abnormal blood cells build up inside a patient’s bone marrow, is Incyte (NASDAQ:INCY) and Novartis’ Jakafi (known as Jakavi outside the U.S.), which is a JAK2 inhibitor. JAK2 is an enzyme that plays a key role in signal transduction; therefore, blocking JAK2 can inhibit the development cytokines that … Continue reading Biotech Volatile Stocks: Incyte Corporation (NASDAQ:INCY), Halozyme Therapeutics (NASDAQ:HALO), Sangamo Biosciences (NASDAQ:SGMO), Nektar Therapeutics (NASDAQ:NKTR)

VIVUS, Inc. (NASDAQ:VVUS) announced that Shari Belafonte is teaming up with the company to educate American adults about seeking medical treatment for chronic weight management when diet and physical activity alone have not been successful. Ms. Belafonte, an actress, model, photographer, writer, singer and daughter of famed musician and actor Harry Belafonte, knows that the impact of being overweight is more than superficial. VIVUS, Inc. … Continue reading Biotech New Lows: VIVUS (NASDAQ:VVUS), Dipexium Pharmaceuticals (NASDAQ:DPRX), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Galmed Pharmaceuticals (NASDAQ:GLMD)

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock performance was -6.80% in last session and finished the day at $24.27. Traded volume was 3.59million shares … Continue reading Biotech Losers: ACADIA Pharmaceuticals (NASDAQ:ACAD), Incyte Corporation (NASDAQ:INCY), Galena Biopharma (NASDAQ:GALE), Alexion Pharmaceuticals (NASDAQ:ALXN)

Hemispherx Biopharma, Inc. (NYSE MKT:HEB) participated in the 11th Biennial International Research and Clinical Conference held in San Francisco, California, USA, March 20-23, 2014. The title of the presentation is “Differential Exercise Responses to Rintatolimod [Ampligen(R)] Exhibited by Patients with Severe Chronic Fatigue Syndrome (CFS)”. This Phase III prospective, double-blind, randomized, placebo-controlled trial was conducted at twelve centers by leading researchers in fatigue and post-exertional … Continue reading Biotech Active Runners: Hemispherx BioPharma (NYSEMKT:HEB), Rexahn Pharmaceuticals (NYSEMKT:RNN), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)